Baseline characteristics

A Study of Oral LBH589 in Adult Patients With Advanced Hematological Malignancies · Source last updated 2021-01-05

Results reported by the registry submitting party. Population, time horizon, units and missing values must be read together.

denoms

1. counts

   1. group Id

      BG000

      value

      86

   2. group Id

      BG001

      value

      34

   3. group Id

      BG002

      value

      33

   4. group Id

      BG003

      value

      23

   5. group Id

      BG004

      value

      176

   units

   Participants

groups

1. description

   panobinostat was administered orally, once-a-day, on Monday-Wednesday-Friday (MWF), every week, as part of a 28-day treatment cycle. Group X indications (AML, CML-BC, AP, CP, ALL, MDS (RAEB-1, -2), MMM, CMML, aCML, CLL, and PLL) is a sub-arm, based on disease indication.

   id

   BG000

   title

   Arm 1, Group X

2. description

   panobinostat was administered orally, once-a-day, on Monday-Wednesday-Friday (MWF), every week, as part of a 28-day treatment cycle. Group Y indications (MM, HL, and NHL) is a sub-arm, based on disease indication.

   id

   BG001

   title

   Arm 1, Group Y

3. description

   panobinostat was administered orally, once-a-day, on Monday-Wednesday-Friday (MWF), every other week, as part of a 28-day treatment cycle. Group X indications (AML, CML-BC, AP, CP, ALL, MDS (RAEB-1, -2), MMM, CMML, aCML, CLL, and PLL) is a sub-arm, based on disease indication.

   id

   BG002

   title

   Arm 2, Group X

4. description

   panobinostat was administered orally, once-a-day, on Monday-Wednesday-Friday (MWF), every other week, as part of a 28-day treatment cycle. Group Y indications (MM, HL, and NHL) is a sub-arm, based on disease indication.

   id

   BG003

   title

   Arm 2, Group Y

5. description

   Total of all reporting groups

   id

   BG004

   title

   Total

measures

1. classes

   1. categories

      1. measurements

         1. group Id

            BG000

            spread

            12.11

            value

            64.2

         2. group Id

            BG001

            spread

            17.27

            value

            41.1

         3. group Id

            BG002

            spread

            8.75

            value

            68.7

         4. group Id

            BG003

            spread

            17.41

            value

            48.3

         5. group Id

            BG004

            spread

            16.97

            value

            58.5

   dispersion Type

   STANDARD_DEVIATION

   param Type

   MEAN

   title

   Age, Continuous

   unit Of Measure

   years

2. classes

   1. categories

      1. measurements

         1. group Id

            BG000

            value

            31

         2. group Id

            BG001

            value

            13

         3. group Id

            BG002

            value

            12

         4. group Id

            BG003

            value

            5

         5. group Id

            BG004

            value

            61

         title

         Female

      2. measurements

         1. group Id

            BG000

            value

            55

         2. group Id

            BG001

            value

            21

         3. group Id

            BG002

            value

            21

         4. group Id

            BG003

            value

            18

         5. group Id

            BG004

            value

            115

         title

         Male

   param Type

   COUNT_OF_PARTICIPANTS

   title

   Sex: Female, Male

   unit Of Measure

   Participants

Download exact source JSON → · Snapshot ctgov-results-25a395029948b04d52b1253f

Preserved source evidence · Not medical advice